Biotech News
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
ir.bluejaydx.com2026-05-06 15:22 EST
ACTON, Mass. , Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 (IL-6), a biomarker relevant to inflammatory and